360° UPSC Mains Analysis

Public health and sanitation, hospitals, and dispensaries fall under Entry 6 of List II (State List) of the Seventh Schedule, making healthcare primarily a state responsibility. However, the Parliament can pass laws on State subjects under Article 252 if two or more States pass resolutions requesting it, which is how the Clinical Establishments (Registration and Regulation) Act, 2010 was enacted and subsequently adopted by various states.

While India's medical tourism sector has been growing rapidly, aggressive corporatisation driven by foreign capital has raised domestic treatment costs. Restricting brownfield FDI (acquisitions) while encouraging greenfield FDI in medical devices and pharmaceuticals will balance the capital account inflows without compromising domestic healthcare affordability. This strategy aims to maintain India's competitive edge in pharmaceutical exports while protecting domestic consumers from market concentration.

High out-of-pocket expenditure (OOPE) at 43.4% of total health expenditure (2022-23) acts as a major drag on household savings and Private Final Consumption Expenditure (PFCE), which constitutes over 55% of India's GDP. Diverting disposable income towards catastrophic healthcare costs reduces aggregate demand in other sectors and limits the fiscal space, as public health spending remains low at 1.43% of GDP against the National Health Policy 2017 target of 2.5%. Rationalizing FDI in hospital acquisitions could prevent monopolistic pricing, stabilizing healthcare-driven inflation within the CPI basket.

The tertiary sector, specifically healthcare services and insurance, will face increased regulatory compliance if standardized package rates and Diagnosis-Related Groups (DRG) are implemented. The medical devices and pharmaceutical manufacturing industries (secondary sector) may see positive growth due to recommended FDI promotion in greenfield projects and domestic manufacturing under the PLI scheme. Conversely, the private hospital corporate sector may experience a consolidation slowdown and compressed profit margins due to proposed caps on room tariffs and reviews of brownfield FDI.

High healthcare costs push approximately 3 to 5 crore Indians into poverty annually, severely impacting informal sector workers who lack social security. Implementing the committee's recommendation to expand low-cost insurance like Aarogya Sanjeevani for the 'missing middle' (estimated at 40 crore uninsured people) will safeguard household livelihoods and prevent debt traps. Additionally, standardizing treatment costs will lower consumer prices for medical services, improving real wages and labor productivity across the economy.

The structural imbalance in India's healthcare system traces back to the late colonial era and early post-independence constitutional choices. The Health Survey and Development Committee, chaired by Sir Joseph Bhore in 1943 (submitting its report in 1946), recommended a comprehensive, state-funded, and free healthcare system to integrate preventive and curative services. However, during the Constituent Assembly debates, public health was placed primarily in the State List (Entry 6 of List II), while Article 47 of the Directive Principles of State Policy (DPSP) designated the improvement of public health as a 'primary duty' of the State. Due to fiscal constraints and competing post-independence priorities, the state-funded model was underfunded, leaving a structural vacuum that paved the way for the growth of unregulated private providers.

Post-independence, India's healthcare policy transitioned from state-led infrastructure building to market-oriented public-private partnerships. The National Health Policy (NHP) of 1983 marked the first major shift, acknowledging the role of private healthcare in filling public sector gaps. Following the 1991 economic reforms, the government actively incentivized private healthcare through tax concessions, subsidized land, and reduced import duties on medical equipment. The Clinical Establishments (Registration and Regulation) Act, 2010 was enacted to set minimum standards for both public and private facilities, but its adoption remains uneven across states. More recently, the National Health Policy of 2017 and the launch of the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in 2018 shifted the state's role from a direct provider to a strategic purchaser of healthcare from private networks.

The current debate over regulating private hospital room tariffs and medical procedures parallels the 1970s and 1980s debates over the Drug Prices Control Orders (DPCO) under the Essential Commodities Act, 1955. Just as the government sought to cap the prices of essential formulations to prevent profiteering by multinational pharmaceutical companies, today's policymakers struggle to balance price caps on medical devices (like coronary stents in 2017) and hospital tariffs with the need to attract private capital.

The demand for universal healthcare was a core tenet of the nationalist struggle, as articulated in the National Planning Committee (NPC) set up by the Indian National Congress in 1938 under Subhas Chandra Bose and chaired by Jawaharlal Nehru, which emphasized that health is a fundamental state responsibility.

The high cost of private healthcare directly erodes the dignity and financial security of families, with catastrophic health expenditures pushing millions of Indians back into poverty annually. It forces individuals to make agonizing choices between life-saving medical treatment and basic livelihoods, education, or ancestral land ownership. Furthermore, the commercialization of care fosters deep-seated public mistrust in the medical profession, transforming patients from individuals seeking healing into mere revenue-generating consumers.

The right to health is an integral part of the Right to Life under Article 21 of the Constitution of India, as upheld by the Supreme Court in State of Punjab v. Ram Lubhaya Bagga (1998). Furthermore, Article 47 (Directive Principles of State Policy) mandates the State to regard the raising of the level of nutrition and the standard of living of its people and the improvement of public health as among its primary duties. Internationally, this aligns with Article 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR), which recognizes the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.

As a District Magistrate, I would face the conflict of 'Equity vs. Efficiency' in balancing the commercial viability of private hospitals (which bring critical capital and technology) against the constitutional right to affordable healthcare for poor citizens. I would also grapple with 'Regulatory Oversight vs. Ease of Doing Business', where enforcing strict price caps or bed reservations under the Clinical Establishments (Registration and Regulation) Act, 2010 might discourage private healthcare investments in underserved rural areas. Lastly, addressing 'Information Asymmetry' presents an ethical challenge in protecting vulnerable patients from profit-driven, unnecessary medical procedures without undermining clinical autonomy.

High out-of-pocket expenditure (OOPE) disproportionately pushes the Economically Weaker Sections (EWS) and rural populations into catastrophic health debt, often forcing them to bypass necessary care. Women face heightened vulnerability due to high private childbirth costs (averaging ₹37,630 compared to ₹2,299 in public facilities), which deters institutional deliveries and risks maternal mortality. The elderly and differently-abled, who require frequent secondary and tertiary interventions, suffer from systemic exclusion due to the commercialization and medicalization of private healthcare.